A Randomised Phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients.

Primary Sponsor

NCIC Clinical Trials Group (NCIC CTG)

Related Post

new TROG Scientific Committee Chair Elect and members
21 July, 2026

New TROG Scientific Committee Chair-Elect and members bring diverse experience

LATEST NEWS: 21 July 2026 The TROG Scientific Committee

RAVES sub-study publication
16 July, 2026

TROG 08.03 RAVES sub-study sheds light on quality of life after post-prostatectomy radiotherapy

LATEST NEWS: 16 July 2026 Secondary analysis of data